@ARTICLE{
author={Donat Dragutin A,Pesic Jasna M,Trifunovic Jasna D,Muzikravic Ljubomir B,Tesanovic Stana M,Donat Daniela D,Pesic Tatjana M},
year={2008},
title={Development of distant metastases during adjuvant therapy with trastuzumab (H) in premenopausal patients with HER2-positive breast cancer},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={26},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Ilic Maja S,Horvat Olga J,Sabo Ana J,Muzikravic Ljubomir B,Jovanovic Darjana,Tomic Zdenko S},
year={2008},
title={Pharmacoeconomic Comparison Of Two Protocols Fac Vs. Cmf In The Treatment Of Early Breast Cancer},
journal={VALUE IN HEALTH},
volume={11},
number={6},
pages={A470-A471},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Pesic Jasna M,Donat Dragutin A,Tesanovic Stana M,Trifunovic Jasna D,Pesic Tatjana M,Donat Daniela D,Muzikravic Ljubomir B},
year={2008},
title={Steroid aromatase inhibitors in metastatic breast cancer after disease progression to nonsteroid inhibitors-efficacy?},
journal={EJC SUPPLEMENTS},
volume={6},
number={7},
pages={178-178},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Donat Dragutin A,Pesic Jasna M,Trifunovic Jasna D,Muzikravic Ljubomir B,Tesanovic Stana M,Donat Daniela D},
year={2008},
title={Factors affecting DFS in triple negative early breast cancer patients - a single institution experience},
journal={EJC SUPPLEMENTS},
volume={6},
number={7},
pages={122-122},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Trifunovic Jasna D,Muzikravic Ljubomir B,Donat Dragutin A,Pesic Jasna M,Salma Svetlana},
year={2006},
title={Accuracy of imaging techniques and tumor marker CA 19-9 in the diagnosis of pancreatic cancer},
journal={ANNALS OF ONCOLOGY},
volume={17},
number={},
pages={326-326},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Pesic Jasna M,Donat Dragutin A,Trifunovic Jasna D,Muzikravic Ljubomir B,Pesic Tatjana M,Donat Daniela D},
year={2006},
title={The efficacy of polychemotherapy combined of cisplatin, endoxan, methotrexate and 5-fluorouracil as a second line therapy for metastatic breast cancer (MBC)},
journal={ANNALS OF ONCOLOGY},
volume={17},
number={},
pages={84-84},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Reid TR,Spears CP,Subramanian M,Pawl L,Jankovic Gradimir M,Jelic Svetislav B,Milinic Nikola,Muzikravic Ljubomir B,Stewart John S,Robbins J},
year={2006},
title={Response to second line treatment following 5,10-methylenetetrahydrofolic acid with 5-fluorouracil as first line treatment in metastatic colorectal cancer},
journal={ANNALS OF ONCOLOGY},
volume={17},
number={},
pages={77-77},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Reid TR,Spears CP,Quadro R,Subramanian M,Pawl L,Jankovic Gradimir M,Jelic Svetislav B,Milinic Nikola,Muzikravic Ljubomir B,Robbins J},
year={2006},
title={5,10-methylenetetrahydrofolic acid with 5-fluorouracil as first line treatment in metastatic colorectal cancer: Phase II study results.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={24},
number={18},
pages={170S-170S},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Reid TR,Spears CP,Quadro R,Subramanian M,Pawl L,Jankovic Gradimir M,Jelic Svetislav B,Milinic Nikola,Muzikravic Ljubomir B},
year={2005},
title={A Simon 2 stage study of 5,10 methylenetetrahydrofolic acid (CO) with 5-fluorouracil (FU) as first line treatment in metastatic colorectal cancer (mCRC).},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={23},
number={16},
pages={293S-293S},
document_type={Meeting Abstract},
}